{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:33:48Z","timestamp":1787726028542,"version":"build-2784847793"},"reference-count":73,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"vor","delay-in-days":3306,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.fertnstert.2014.09.041","type":"journal-article","created":{"date-parts":[[2014,10,24]],"date-time":"2014-10-24T07:01:20Z","timestamp":1414134080000},"page":"119-130.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":168,"title":["Antim\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2500-9904","authenticated-orcid":false,"given":"Reshef","family":"Tal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oded","family":"Tal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Seifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Seifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2014.09.041_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1530\/REP-09-0415","article-title":"Anti-Mullerian hormone and polycystic ovary syndrome: a mountain too high?","volume":"139","author":"Pellatt","year":"2010","journal-title":"Reproduction"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.fertnstert.2007.02.014","article-title":"Mullerian inhibiting substance is an ovarian growth factor of emerging clinical significance","volume":"88","author":"Seifer","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/humrep\/der446","article-title":"Anti-Mullerian hormone: clairvoyance or crystal clear?","volume":"27","author":"Nelson","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.GME.0000123642.76105.6E","article-title":"Anti-mullerian hormone is a promising predictor for the occurrence of the menopausal transition","volume":"11","author":"van Rooij","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0015-0282(01)02993-4","article-title":"Antimullerian hormone serum levels: a putative marker for ovarian aging","volume":"77","author":"de Vet","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib7","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-Mullerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib8","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/humrep\/deh819","article-title":"Anti-Mullerian hormone concentrations in maternal serum during pregnancy","volume":"20","author":"La Marca","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejogrb.2007.01.012","article-title":"Anti-Mullerian hormone levels during hormonal contraception in women with polycystic ovary syndrome","volume":"134","author":"Somunkiran","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis","volume":"17","author":"Broer","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib11","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1093\/humrep\/dei203","article-title":"Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome","volume":"20","author":"Eldar-Geva","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib12","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dem204","article-title":"Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles\u2014implications for individualization of therapy","volume":"22","author":"Nelson","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humrep\/dei270","article-title":"Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology","volume":"21","author":"Silberstein","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib14","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1210\/jc.2006-1053","article-title":"Anti-Mullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in\u00a0vitro fertilization","volume":"92","author":"Fanchin","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/humrep\/deh718","article-title":"Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist\u2013gonadotropin treatment","volume":"20","author":"Penarrubia","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.fertnstert.2005.09.019","article-title":"Early follicular antimullerian hormone as an indicator of ovarian reserve","volume":"85","author":"Ficicioglu","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.fertnstert.2006.06.019","article-title":"Antimullerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in\u00a0vitro fertilization or intracyoplasmic sperm injection","volume":"87","author":"Smeenk","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmu003","article-title":"The predictive accuracy of anti-Mullerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature","volume":"20","author":"Iliodromiti","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach","volume":"19","author":"Broer","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib20","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1210\/jc.2012-3676","article-title":"Antimullerian hormone levels are strongly associated with live-birth rates after assisted reproduction","volume":"98","author":"Brodin","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib21","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/humrep\/des101","article-title":"The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments","volume":"27","author":"Anckaert","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib22","doi-asserted-by":"crossref","first-page":"223.e1","DOI":"10.1016\/j.ajog.2011.04.035","article-title":"Use of in-cycle antimullerian hormone levels to predict cycle outcome","volume":"205","author":"Blazar","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib23","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","article-title":"Antimullerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients","volume":"99","author":"Arce","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10815-012-9754-6","article-title":"Serum anti-mullerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF\/ICSI cycles","volume":"29","author":"Sahmay","year":"2012","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib25","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00404-011-1979-6","article-title":"Different serum anti-Mullerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes","volume":"284","author":"Irez","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib26","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.fertnstert.2010.04.067","article-title":"Anti-Mullerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve","volume":"94","author":"Gleicher","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib27","first-page":"715","article-title":"Anti-mullerian hormone as a predictive factor in assisted reproductive technique of polycystic ovary syndrome patients","volume":"49","author":"Aleyasin","year":"2011","journal-title":"Acta Med Iran"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib28","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.fertnstert.2009.12.002","article-title":"Serum antimullerian hormone concentrations on day 3 of the in\u00a0vitro fertilization stimulation cycle are predictive of the fertilization, implantation, and pregnancy in polycystic ovary syndrome patients undergoing assisted reproduction","volume":"94","author":"Kaya","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10815-012-9726-x","article-title":"Correlation of serum Anti-Mullerian hormone concentrations on day 3 of the in\u00a0vitro fertilization stimulation cycle with assisted reproduction outcome in polycystic ovary syndrome patients","volume":"29","author":"Xi","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3109\/09513590.2013.769519","article-title":"Anti-Mullerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in\u00a0vitro fertilization patients","volume":"29","author":"Sahmay","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib31","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.fertnstert.2011.03.071","article-title":"Random anti-Mullerian hormone (AMH) is a predictor of ovarian response in women with elevated baseline early follicular follicle-stimulating hormone levels","volume":"95","author":"Buyuk","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1479-828X.2011.01374.x","article-title":"Using anti-Mullerian hormone to identify a good prognosis group in women of advanced reproductive age","volume":"51","author":"Friden","year":"2011","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib33","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s10815-013-0077-z","article-title":"Determining an anti-Mullerian hormone cutoff level to predict clinical pregnancy following in\u00a0vitro fertilization in women with severely diminished ovarian reserve","volume":"30","author":"Merhi","year":"2013","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.gyobfe.2012.02.001","article-title":"[Low circulating anti-Mullerian hormone and normal follicle stimulating hormone levels: which prognosis in an IVF program?]","volume":"40","author":"Grzegorczyk-Martin","year":"2012","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib35","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.fertnstert.2008.08.110","article-title":"Variations in serum mullerian inhibiting substance between white, black, and Hispanic women","volume":"92","author":"Seifer","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib36","doi-asserted-by":"crossref","first-page":"59.e1","DOI":"10.1016\/j.ajog.2014.02.026","article-title":"Characterization of women with elevated antimullerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes","volume":"211","author":"Tal","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib37","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.rbmo.2010.06.041","article-title":"The association between anti-Mullerian hormone and IVF pregnancy outcomes is influenced by age","volume":"21","author":"Wang","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib38","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib39","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/sim.1970","article-title":"Funnel plots for comparing institutional performance","volume":"24","author":"Spiegelhalter","year":"2005","journal-title":"Stat Med"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib40","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","article-title":"The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed","volume":"58","author":"Deeks","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2288-6-31","article-title":"Meta-DiSc: a software for meta-analysis of test accuracy data","volume":"6","author":"Zamora","year":"2006","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/biostatistics\/kxl004","article-title":"A unification of models for meta-analysis of diagnostic accuracy studies","volume":"8","author":"Harbord","year":"2007","journal-title":"Biostatistics"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib43","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib45","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib46","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1472-6483(10)61053-X","article-title":"Anti-Mullerian hormone as a predictor of IVF outcome","volume":"14","author":"Lekamge","year":"2007","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib47","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10815-013-9973-5","article-title":"The predictive value of anti-Mullerian hormone on embryo quality, blastocyst development, and pregnancy rate following in\u00a0vitro fertilization-embryo transfer (IVF-ET)","volume":"30","author":"Lin","year":"2013","journal-title":"J\u00a0Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib48","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.fertnstert.2007.07.1293","article-title":"Evaluation of anti-Mullerian hormone as a test for the prediction of ovarian reserve","volume":"90","author":"Kwee","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib49","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.fertnstert.2004.03.061","article-title":"Serum antimullerian hormone\/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol","volume":"82","author":"Hazout","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib50","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/j.fertnstert.2007.10.078","article-title":"Anti-Mullerian hormone and inhibin B as predictors of pregnancy after treatment by in\u00a0vitro fertilization\/intracytoplasmic sperm injection","volume":"90","author":"Wunder","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1477-7827-7-100","article-title":"Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cycles","volume":"7","author":"Lee","year":"2009","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib52","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.rbmo.2012.12.002","article-title":"Anti-Mullerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles","volume":"26","author":"Tal","year":"2013","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib53","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/humupd\/dms043","article-title":"The ageing ovary and uterus: new biological insights","volume":"19","author":"Nelson","year":"2013","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib54","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.fertnstert.2004.06.001","article-title":"Mullerian-inhibiting substance in women with polycystic ovary syndrome: relationship with hormonal and metabolic characteristics","volume":"82","author":"La Marca","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib55","doi-asserted-by":"crossref","first-page":"E238","DOI":"10.1152\/ajpendo.90684.2008","article-title":"Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels","volume":"296","author":"Piouka","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib56","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.fertnstert.2011.04.003","article-title":"Antimullerian hormone and polycystic ovary syndrome","volume":"96","author":"Lin","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib57","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1210\/jc.2003-030727","article-title":"Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest","volume":"88","author":"Pigny","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib58","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/jc.2013-1393","article-title":"Can anti-Mullerian hormone predict the diagnosis of polycystic ovary syndrome? A systematic review and meta-analysis of extracted data","volume":"98","author":"Iliodromiti","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib59","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/humrep\/deu053","article-title":"Association between response to ovarian stimulation and miscarriage following IVF: an analysis of 124 351 IVF pregnancies","volume":"29","author":"Sunkara","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib60","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib61","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S1472-6483(10)61034-6","article-title":"What can the clinician do to improve implantation?","volume":"13","author":"Boomsma","year":"2006","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib62","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/humrep\/del127","article-title":"Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles","volume":"21","author":"Ebner","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib63","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejogrb.2010.02.029","article-title":"The use of anti-Mullerian hormone and antral follicle count to predict the potential of oocytes and embryos","volume":"150","author":"Majumder","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib64","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.fertnstert.2007.03.080","article-title":"Anti-Mullerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in\u00a0vitro fertilization","volume":"89","author":"Takahashi","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib65","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1472-6483(10)60480-4","article-title":"Anti-Mullerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?","volume":"16","author":"Lie Fong","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib66","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.fertnstert.2010.07.1042","article-title":"Anti-Mullerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation","volume":"95","author":"Riggs","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib67","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ando.2009.03.007","article-title":"Serum antimullerian hormone is not predictive of oocyte quality in\u00a0vitro fertilization","volume":"70","author":"Guerif","year":"2009","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib68","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/GCO.0b013e3282fe723d","article-title":"Assessment of embryo viability in assisted reproductive technology: shortcomings of current approaches and the emerging role of metabolomics","volume":"20","author":"Bromer","year":"2008","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib69","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.fertnstert.2013.01.089","article-title":"Selection of high potential embryos using time-lapse imaging: the era of morphokinetics","volume":"99","author":"Herrero","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib70","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/AOG.0b013e318278eeda","article-title":"Association of abnormal ovarian reserve parameters with a higher incidence of aneuploid blastocysts","volume":"121","author":"Katz-Jaffe","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib71","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1210\/jc.2006-0331","article-title":"Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation","volume":"91","author":"Hehenkamp","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib72","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.fertnstert.2013.10.021","article-title":"Reference range for the antimullerian hormone Generation II assay: a population study of 10,984 women, with comparison to the established Diagnostics Systems Laboratory nomogram","volume":"101","author":"Nelson","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2014.09.041_bib73","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1210\/jc.2013-3476","article-title":"The measurement of anti-mullerian hormone: a critical appraisal","volume":"99","author":"Rustamov","year":"2014","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214022237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028214022237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:16:40Z","timestamp":1758010600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028214022237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0015028214022237"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.09.041","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antim\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2014.09.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}